HEPION PHARMACEUTICALS, INC. Operating Lease, Liability, Current
HEPION PHARMACEUTICALS, INC. (HEPA) had Operating Lease, Liability, Current of $117.95 thousand as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2025-04-08
- 2024-09-30: Operating Lease, Liability, Current $117.95K.
- 2024-06-30: Operating Lease, Liability, Current $154.09K.
- 2024-03-31: Operating Lease, Liability, Current $134.02K.
- 2023-12-31: Operating Lease, Liability, Current $115.92K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2024-09-30 | $117.95K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $154.09K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $134.02K 10-Q · filed 2024-05-21 |
| 2023-12-31 | $115.92K 10-K · filed 2025-04-08 |
| 2023-09-30 | $112.28K 10-Q · filed 2023-11-20 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-12 |
| 2022-12-31 | $53.61K 10-K · filed 2024-04-16 |
| 2022-09-30 | $105.58K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $176.86K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $247.34K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $266.65K 10-K · filed 2023-04-10 |
| 2021-09-30 | $285.28K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $286.02K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $211.14K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $279.83K 10-K · filed 2022-04-08 |
| 2020-09-30 | $275.30K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $274.60K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $273.09K 10-Q · filed 2020-06-29 |
| 2019-12-31 | $266.70K 10-K · filed 2021-03-31 |
| 2019-09-30 | $191.25K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $190.63K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $190.04K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |